132 related articles for article (PubMed ID: 31266829)
1. DNA-Dependent Protein Kinase Drives Prostate Cancer Progression through Transcriptional Regulation of the Wnt Signaling Pathway.
Kothari V; Goodwin JF; Zhao SG; Drake JM; Yin Y; Chang SL; Evans JR; Wilder-Romans K; Gabbara K; Dylgjeri E; Chou J; Sun G; Tomlins SA; Mehra R; Hege K; Filvaroff EH; Schaeffer EM; Karnes RJ; Quigley DA; Rathkopf DE; He HH; Speers C; Spratt DE; Gilbert LA; Ashworth A; Chinnaiyan AM; Raj GV; Knudsen KE; Feng FY
Clin Cancer Res; 2019 Sep; 25(18):5608-5622. PubMed ID: 31266829
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of protein kinase, DNA-activated, catalytic polypeptide attenuates tumor progression and is an independent prognostic predictor of survival in prostate cancer.
Zhang X; Wang Y; Ning Y
Urol Oncol; 2017 Mar; 35(3):111.e15-111.e23. PubMed ID: 27856181
[TBL] [Abstract][Full Text] [Related]
3. PHF21B overexpression promotes cancer stem cell-like traits in prostate cancer cells by activating the Wnt/β-catenin signaling pathway.
Li Q; Ye L; Guo W; Wang M; Huang S; Peng X
J Exp Clin Cancer Res; 2017 Jun; 36(1):85. PubMed ID: 28645312
[TBL] [Abstract][Full Text] [Related]
4. TRAF4-mediated ubiquitination of NGF receptor TrkA regulates prostate cancer metastasis.
Singh R; Karri D; Shen H; Shao J; Dasgupta S; Huang S; Edwards DP; Ittmann MM; O'Malley BW; Yi P
J Clin Invest; 2018 Jul; 128(7):3129-3143. PubMed ID: 29715200
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the ERG-regulated Kinome in Prostate Cancer Identifies TNIK as a Potential Therapeutic Target.
Lee RS; Zhang L; Berger A; Lawrence MG; Song J; Niranjan B; Davies RG; Lister NL; Sandhu SK; Rubin MA; Risbridger GP; Taylor RA; Rickman DS; Horvath LG; Daly RJ
Neoplasia; 2019 Apr; 21(4):389-400. PubMed ID: 30901730
[TBL] [Abstract][Full Text] [Related]
6. Pleiotropic Impact of DNA-PK in Cancer and Implications for Therapeutic Strategies.
Dylgjeri E; McNair C; Goodwin JF; Raymon HK; McCue PA; Shafi AA; Leiby BE; de Leeuw R; Kothari V; McCann JJ; Mandigo AC; Chand SN; Schiewer MJ; Brand LJ; Vasilevskaya I; Gordon N; Laufer TS; Gomella LG; Lallas CD; Trabulsi EJ; Feng FY; Filvaroff EH; Hege K; Rathkopf D; Knudsen KE
Clin Cancer Res; 2019 Sep; 25(18):5623-5637. PubMed ID: 31266833
[TBL] [Abstract][Full Text] [Related]
7. Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation.
Mahajan NP; Liu Y; Majumder S; Warren MR; Parker CE; Mohler JL; Earp HS; Whang YE
Proc Natl Acad Sci U S A; 2007 May; 104(20):8438-43. PubMed ID: 17494760
[TBL] [Abstract][Full Text] [Related]
8. ZNF507 affects TGF-β signaling via TGFBR1 and MAP3K8 activation in the progression of prostate cancer to an aggressive state.
Kwon W; Choi SK; Kim D; Kim HG; Park JK; Han JE; Cho GJ; Yun S; Yu W; Han SH; Ha YS; Lee JN; Kwon TG; Cho DH; Yi JK; Kim MO; Ryoo ZY; Park S
J Exp Clin Cancer Res; 2021 Sep; 40(1):291. PubMed ID: 34537073
[TBL] [Abstract][Full Text] [Related]
9. DNA-PKcs-Mediated Transcriptional Regulation Drives Prostate Cancer Progression and Metastasis.
Goodwin JF; Kothari V; Drake JM; Zhao S; Dylgjeri E; Dean JL; Schiewer MJ; McNair C; Jones JK; Aytes A; Magee MS; Snook AE; Zhu Z; Den RB; Birbe RC; Gomella LG; Graham NA; Vashisht AA; Wohlschlegel JA; Graeber TG; Karnes RJ; Takhar M; Davicioni E; Tomlins SA; Abate-Shen C; Sharifi N; Witte ON; Feng FY; Knudsen KE
Cancer Cell; 2015 Jul; 28(1):97-113. PubMed ID: 26175416
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-744 promotes prostate cancer progression through aberrantly activating Wnt/β-catenin signaling.
Guan H; Liu C; Fang F; Huang Y; Tao T; Ling Z; You Z; Han X; Chen S; Xu B; Chen M
Oncotarget; 2017 Feb; 8(9):14693-14707. PubMed ID: 28107193
[TBL] [Abstract][Full Text] [Related]
11. Decreased HoxD10 Expression Promotes a Proliferative and Aggressive Phenotype in Prostate Cancer.
Mo RJ; Lu JM; Wan YP; Hua W; Liang YX; Zhuo YJ; Kuang QW; Liu YL; He HC; Zhong WD
Curr Mol Med; 2017; 17(1):70-78. PubMed ID: 28231752
[TBL] [Abstract][Full Text] [Related]
12. Capn4 expression is modulated by microRNA-520b and exerts an oncogenic role in prostate cancer cells by promoting Wnt/β-catenin signaling.
Ren W; Wang D; Li C; Shu T; Zhang W; Fu X
Biomed Pharmacother; 2018 Dec; 108():467-475. PubMed ID: 30241050
[TBL] [Abstract][Full Text] [Related]
13. ETS transcription factor ESE1/ELF3 orchestrates a positive feedback loop that constitutively activates NF-κB and drives prostate cancer progression.
Longoni N; Sarti M; Albino D; Civenni G; Malek A; Ortelli E; Pinton S; Mello-Grand M; Ostano P; D'Ambrosio G; Sessa F; Garcia-Escudero R; Thalmann GN; Chiorino G; Catapano CV; Carbone GM
Cancer Res; 2013 Jul; 73(14):4533-47. PubMed ID: 23687337
[TBL] [Abstract][Full Text] [Related]
14. miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer.
Cai C; Chen QB; Han ZD; Zhang YQ; He HC; Chen JH; Chen YR; Yang SB; Wu YD; Zeng YR; Qin GQ; Liang YX; Dai QS; Jiang FN; Wu SL; Zeng GH; Zhong WD; Wu CL
Clin Cancer Res; 2015 Nov; 21(21):4922-34. PubMed ID: 26080838
[TBL] [Abstract][Full Text] [Related]
15. A novel non-canonical Wnt signature for prostate cancer aggressiveness.
Sandsmark E; Hansen AF; Selnæs KM; Bertilsson H; Bofin AM; Wright AJ; Viset T; Richardsen E; Drabløs F; Bathen TF; Tessem MB; Rye MB
Oncotarget; 2017 Feb; 8(6):9572-9586. PubMed ID: 28030815
[TBL] [Abstract][Full Text] [Related]
16. Dickkopf 2 promotes proliferation and invasion via Wnt signaling in prostate cancer.
Xu W; Pang K; Zhou ZG; Chen YF; Mo T; Li M; Liu CB
Mol Med Rep; 2016 Sep; 14(3):2283-8. PubMed ID: 27431620
[TBL] [Abstract][Full Text] [Related]
17. An
Lu X; Pan X; Wu CJ; Zhao D; Feng S; Zang Y; Lee R; Khadka S; Amin SB; Jin EJ; Shang X; Deng P; Luo Y; Morgenlander WR; Weinrich J; Lu X; Jiang S; Chang Q; Navone NM; Troncoso P; DePinho RA; Wang YA
Cancer Res; 2018 Jul; 78(14):3823-3833. PubMed ID: 29769196
[TBL] [Abstract][Full Text] [Related]
18. SOX9 drives WNT pathway activation in prostate cancer.
Ma F; Ye H; He HH; Gerrin SJ; Chen S; Tanenbaum BA; Cai C; Sowalsky AG; He L; Wang H; Balk SP; Yuan X
J Clin Invest; 2016 May; 126(5):1745-58. PubMed ID: 27043282
[TBL] [Abstract][Full Text] [Related]
19. MiR-182 promotes prostate cancer progression through activating Wnt/β-catenin signal pathway.
Wang D; Lu G; Shao Y; Xu D
Biomed Pharmacother; 2018 Mar; 99():334-339. PubMed ID: 29353209
[TBL] [Abstract][Full Text] [Related]
20. NUSAP1 promotes invasion and metastasis of prostate cancer.
Gordon CA; Gong X; Ganesh D; Brooks JD
Oncotarget; 2017 May; 8(18):29935-29950. PubMed ID: 28404898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
